Chen PW, Minocha M, Kong S, Jiang T, et al. Tarlatamab exposure-efficacy and exposure-safety relationships to inform dose selection in patients with small cell lung cancer (SCLC). Clin Cancer Res 2025 Sep 10. doi: 10.1158/1078-0432.CCR-25-2134.
PMID: 40928991